N-Nitroso Pantoprazole EP Impurity A
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

N-Nitroso Pantoprazole EP Impurity A

● Under Development

Katalog-Nr.::VE0013068
CAS-Nr.::N/A
Summenformel::C16H14F2N4O6S
Molare Masse::428.4 g/mol

Zusätzliche Informationen zu N-Nitroso Pantoprazole EP Impurity A

Parent drug

Pantoprazole

IUPAC-Name

5-(difluoromethoxy)-2-(((3, 4-dimethoxypyridin-2-yl)methyl)sulfonyl)-1-nitroso-1H-benzo[d]imidazole

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

O=NN1C(S(=O)(CC2=NC=CC(OC)=C2OC)=O)=NC3=CC(OC(F)F)=CC=C13

InChl

InChI=1S/C16H14F2N4O6S/c1-26-13-5-6-19-11(14(13)27-2)8-29(24,25)16-20-10-7-9(28-15(17)18)3-4-12(10)22(16)21-23/h3-7,15H,8H2,1-2H3InChI=1S/C16H14F2N4O6S/c1-26-13-5-6-19-11(14(13)27-2)8-29(24,25)16-20-10-7-9(28-15(17)18)3-4-12(10)22(16)21-23/h3-7,15H,8H2,1-2H3InChI=1S/C16H14F2N4O6S/c1-26-13-5-6-19-11(14(13)27-2)8-29(24,25)16-20-10-7-9(28-15(17)18)3-4-12(10)22(16)21-23/h3-7,15H,8H2,1-2H3

Beschreibung

N-Nitroso Pantoprazole EP Impurity A is an N-nitroso derivative of the secondary amine present in Pantoprazole | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Pantoprazole production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url